Hubbard, R; Farrington, P; Smith, C; Smeeth, L; Tattersfield, A; (2003) Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. American journal of epidemiology, 158 (1). pp. 77-84. ISSN 0002-9262 DOI: https://doi.org/10.1093/aje/kwg114 Full text not available from this repository.

Ritchie, CW; Ames, D; Clayton, T; Lai, R; (2004) Metaanalysis of randomized trials of the efficacy and safety of Donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease. The American journal of geriatric psychiatry, 12 (4). p. 358. ISSN 1064-7481 DOI: https://doi.org/10.1176/appi.ajgp.12.4.358 Full text not available from this repository.

Tata, LJ; West, J; Smith, C; Farrington, P; Card, T; Smeeth, L; Hubbard, R; (2005) General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart (British Cardiac Society). p. 465. ISSN 1355-6037 DOI: https://doi.org/10.1136/hrt.2004.037457 Full text not available from this repository.

Verheugt, FWA; Clemmensen, P; Mehran, R; Agewall, S; Pocock, SJ; Goldstein, S; Torp-Pedersen, C; Simoons, ML; Borer, JS; Khder, YM; +6 more... Burton, P; Deliargyris, E; McMurray, JJV; Berkowitz, SD; Stough, WG; Zannad, F; (2013) Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy. European heart journal, 34 (22). 1621-+. ISSN 0195-668X DOI: https://doi.org/10.1093/eurheartj/eht013 Full text not available from this repository.